Jadhav Ashwini Khanderao, Karuppayil Sankunny Mohan
Department of Stem Cell and Regenerative Medicine, Centre for Interdisciplinary Research, DY Patil Education Society (Deemed to be University), (NAAC Re Accredited with 'A' Grade), Kolhapur, Maharashtra 416006 India.
In Silico Pharmacol. 2021 Mar 26;9(1):24. doi: 10.1007/s40203-021-00082-1. eCollection 2021.
Fluoroquinolines, the widely used antibacterial antibiotics, have been shown to interact with human DNA topoisomerases supporting their use as repurposed cancer drugs in humans. In this communication molecular docking of eleven Fluoroquinolines against predicted structure of Topoisomerase II is reported for the first time. topoisomerase II structure prediction was done by using homology modeling tool. Ligand preparation and molecular docking with topoisomerase II were done by using Autodock tool. These antibiotics formed hydrogen bond with good binding affinity at ARG 841, GLN803, ALA840 amino acid residues in the active site of Topoisomerase II. We hypothesize that DNA toposiomerases may be the targets of Fluroquinoline group of antibiotics in causing inhibition of growth.
氟喹诺酮类药物是广泛使用的抗菌抗生素,已被证明可与人类DNA拓扑异构酶相互作用,这支持了它们作为人类癌症药物重新利用的用途。在本通讯中,首次报道了11种氟喹诺酮类药物针对拓扑异构酶II预测结构的分子对接。拓扑异构酶II结构预测通过使用同源建模工具完成。配体制备和与拓扑异构酶II的分子对接通过使用Autodock工具完成。这些抗生素在拓扑异构酶II活性位点的ARG 841、GLN803、ALA840氨基酸残基处形成具有良好结合亲和力的氢键。我们假设DNA拓扑异构酶可能是氟喹诺酮类抗生素导致生长抑制的靶点。